|
Current News Index News Archives View Weight Management Products |
Obese Men More Likely to Get Cataracts By Jeremy Appleton, ND Healthnotes Newswire (December 21 & 28, 2000)—Obesity is associated with an increased risk of cataracts, according to a new analysis of data from the Physicians’ Health Study. The new research1 found that men who met the clinical criteria for obesity (as determined by their “body mass index”) were significantly more likely to develop a cataract (lens opacity of the eye, causing progressive vision loss) than were men of normal body weight. The body mass index (BMI) is calculated by dividing the body weight in kilograms by the height in meters squared (kg/m2). A BMI of greater than or equal to 30 is considered obese. To date, most,2 3 4 5 but not all,6 7 population studies have found an increased risk of cataracts as BMI increases. The current study, which was published in this month’s edition of the American Journal of Clinical Nutrition, followed over 17,000 apparently healthy male physicians for an average of 14 years. None of the men in the study had a cataract at the beginning of the study. At the end of the follow-up period, approximately 10% of the study participants had developed cataracts. Men with the highest BMI had a 25% greater chance of developing a cataract than did men with the lowest BMI. Another measure of obesity, the waist-to-hip ratio (WHR), also correlated with increased risk; men in the highest WHR category had a 31% higher risk of cataracts than did men in the lowest WHR category. Cataracts are the leading cause of blindness worldwide, accounting for nearly half of all cases.8 The risk of cataracts increases as people age. However, though many people mistakenly assume cataracts are an inevitable consequence of aging, the disease is considered preventable. Delaying the onset of cataracts nationwide would have an enormous impact on healthcare expenditures. It has been estimated that delaying the onset of cataracts by ten years would cut the U.S. cataract surgery rate in half.9 How Can Obesity Cause Blindness? No study, the present one included, has shown that obesity causes cataracts. Studies such as this one, called prospective follow-up studies, cannot prove cause-and-effect; they can only demonstrate risks. Nevertheless, there are several possible explanations of why obesity might contribute to the development of cataracts, and therefore to blindness. Obesity is a risk factor for gout, which has been found to predispose to cataracts.6 10 11 Overweight individuals may also have higher amounts of systemic inflammation,12 which may be a risk factor for cataracts.13 Finally, obesity is a strong risk factor for glucose intolerance and insulin resistance, conditions that are involved in the development of type 2 (adult-onset) diabetes.14 15 Diabetes is well known to cause or accelerate cataract formation. The Study’s Limitations Data on glucose intolerance and insulin resistance were missing from the present study, so the role of these conditions in contributing to the higher incidence of cataracts among obese men could not be evaluated. Also, though researchers were able to control the effects of various confounding variables on their data, they were not able to control for the dietary presence of certain potentially protective nutrients, such as vitamin A, niacin, thiamine, and riboflavin. Moreover, because men with higher BMIs and WHRs tended to consume fewer servings of fruit, vegetables, and whole grains, it is possible that the increased risk of cataracts observed in these men may have been due to diets that were relatively deficient in important vitamins and minerals. The Perils of Obesity Obesity is an epidemic in the United States (see Healthnotes Newswire October 5, 2000 edition). Although the results from this study are far from conclusive, they add to the growing list of diseases for which obese people appear to be at greater risk. These include cardiovascular diseases (e.g., coronary heart disease, hypertension),16 type 2 diabetes,17 18 prostate enlargement (called benign prostatic hyperplasia, or BPH),19 gallstones,20 certain cancers (e.g., breast cancer in postmenopausal women, and cancers of the uterus, colon, and kidney),21 female infertility,22 uterine fibroids,23 work disability,24 and overall mortality.25 The risk of death from cardiovascular disease, cancer, or other diseases increases in overweight men and women in all age groups.26 References1. Schaumberg DA, Glynn RJ, Christen WG, et al. Relations of body fat distribution and height with cataracts in men. Am J Clin Nutr 2000;72:1495–502. 2. Glynn RJ, Christen WG, Manson JE, et al. Body mass index. An independent predictor of cataract. Arch Ophthalmol 1995;113:1131–7. 3. Hankinson SE, Seddon JM, Colditz GA, et al. A prospective study of aspirin use and cataract extraction in women. Arch Ophthalmol 1993;111:503–8. 4. Hiller R, Podgor MJ, Sperduto RD, et al. A longitudinal study of body mass index and lens opacities. The Framingham Studies. Ophthalmology 1998;105:1244–50. 5. Tavani A, Negri E, La Vecchia C. Selected diseases and risk of cataract in women. A case-control study from northern Italy. Ann Epidemiol 1995;5:234–8. 6. Leske MC, Chylack LT Jr, Wu SY. The Lens Opacities Case-Control Study. Risk factors for cataract. Arch Ophthalmol 1991;109:244–51. 7. Mohan M, Sperduto RD, Angra SK, et al. India-US case-control study of age-related cataracts. India-US Case-Control Study Group. Arch Ophthalmol 1989;107:670–6. [published erratum appears in Arch Ophthalmol 1989;107:1288.] 8. Thylefors B, Negrel AD, Pararajasegaram R, Dadzie KY. Global data on blindness. Bull World Health Organ 1995;73:115–21 [review]. 9. Kupfer C. The conquest of cataract: a global challenge. Trans Ophthalmol Soc U K 1994;104:1–101. 10. [No authors listed]. Risk factors for age-related cortical, nuclear, and posterior subcapsular cataracts. The Italian-American Cataract Study Group. Am J Epidemiol 1991;133:541–53. 11. Leske MC, Wu SY, Hyman L, et al. Biochemical factors in the lens opacities. Case-control study. The Lens Opacities Case-Control Study Group. Arch Ophthalmol 1995;113:1113–9. 12. Mendall MA, Patel P, Ballam L, et al. C reactive protein and its relation to cardiovascular risk factors: a population based cross sectional study. BMJ 1996;312:1061–5. 13. Schaumberg DA, Ridker PM, Glynn RJ, et al. High levels of plasma C-reactive protein and future risk of age-related cataract. Ann Epidemiol 1999;9:166–71. 14. Uusitupa M, Louheranta A, Lindstrom J, et al. The Finnish Diabetes Prevention Study. Br J Nutr 2000;83 Suppl 1:S137–42. 15. Carlsson S, Persson PG, Alvarsson M, et al. Weight history, glucose intolerance, and insulin levels in middle-aged Swedish men. Am J Epidemiol 1998;148:539–45. 16. Hubert HB, Feinleib M, McNamara PM, Castelli WP. Obesity as an independent risk factor for cardiovascular disease: a 26-year follow-up of participants in the Framingham Heart Study. Circulation 1983;67:968–77. 17. Isida K, Mizuno A, Murakami T, Shima K. Obesity is necessary but not sufficient for the development of diabetes mellitus. Metabolism 1996;45:1288–95. 18. Pi-Sunyer FX. Weight and non-insulin-dependent diabetes mellitus. Am J Clin Nutr 1996;63(suppl):426S–9S. 19. Soygur T, Kupeli B, Aydos K, et al. Effect of obesity on prostatic hyperplasia: its relation to sex steroid levels. Int Urol Nephrol 1996;28:55–9. 20. Syngal S, Coakley EH, Willett WC, et al. Long-term weight patterns and risk for cholecystectomy in women. Ann Intern Med 1999 16;130:471–7. 21. Carroll KK. Obesity as a risk factor for certain types of cancer. Lipids 1998;33:1055–9. 22. Green BB, Weiss NS, Daling JR. Risk of ovulatory infertility in relation to body weight. Fertil Steril 1988;50:621–6. 23. Sato F, Nishi M, Kudo R, Miyake H. Body fat distribution and uterine leiomyomas. J Epidemiol 1998;8:176–80. 24. Rissanen A, Heliovaara M, Knekt P, et al. Risk of disability and mortality due to overweight in a Finnish population. BMJ 1990;301:835–7. 25. Solomon CG, Manson JE. Obesity and mortality: a review of epidemiologic data. Am J Clin Nutr 1997;66:1044S–50S. 26. Calle EE, Thun MJ, Petrelli JM, et al. Body-mass index and mortality in a prospective cohort of U.S. adults. N Engl J Med 1999;341:1097–105. Jeremy Appleton, ND, is a licensed naturopathic physician, writer, and educator in the field of evidence-based complementary and alternative medicine. Dr. Appleton is Chair of Nutrition at the National College of Naturopathic Medicine and Senior Science Editor at Healthnotes. This article is provided by Healthnotes for theBetterHealthStore. Copyright © 2000 Healthnotes, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
HOME PAGE | PRODUCTS | BRANDS | SALE | CONTACT Information presented at theBetterHealthStore.com is for educational purposes only; statements about products and health conditions have not been evaluated by the U.S. Food & Drug Administration. Copyright ©2000 theBetterHealthStore.com Inc. |